Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1986 Jan;49(1):87–89. doi: 10.1136/jnnp.49.1.87

The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry.

D A Francis, D Grundy, J R Heron
PMCID: PMC1028653  PMID: 3958735

Abstract

Isonicotinic acid hydrazide (isoniazid) was evaluated in five patients as a treatment for the control of severe cerebellar action tremor occurring in multiple sclerosis. Oral doses of isoniazid BPC were increased every 2 weeks from 300 mg to 1200 mg daily over an 8 week period. Four patients reported considerable symptomatic benefit at doses ranging from 600 mg to 900 mg daily. Polarised light goniometry demonstrated a two to three-fold reduction of tremor in these patients when standard methods of clinical assessment showed only marginal improvement.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achar V. S., Welch K. M., Chabi E., Bartosh K., Meyer J. S. Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease. Neurology. 1976 Aug;26(8):777–780. doi: 10.1212/wnl.26.8.777. [DOI] [PubMed] [Google Scholar]
  2. KURTZKE J. F. FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS. Neurology. 1965 Jul;15:654–661. doi: 10.1212/wnl.15.7.654. [DOI] [PubMed] [Google Scholar]
  3. Kuroda H., Ogawa N., Yamawaki Y., Nukina I., Ofuji T., Yamamoto M., Otsuki S. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases. J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):257–260. doi: 10.1136/jnnp.45.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MAHER J. R., WHITNEY J. M., CHAMBERS J. S., STANONIS D. J. The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids. Am Rev Tuberc. 1957 Nov;76(5):852–861. doi: 10.1164/artpd.1957.76.5.852. [DOI] [PubMed] [Google Scholar]
  5. McLean D. R. Failure of isoniazid therapy in Huntington disease. Neurology. 1982 Oct;32(10):1189–1191. doi: 10.1212/wnl.32.10.1189. [DOI] [PubMed] [Google Scholar]
  6. Perry T. L., Hansen S., Kloster M. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med. 1973 Feb 15;288(7):337–342. doi: 10.1056/NEJM197302152880703. [DOI] [PubMed] [Google Scholar]
  7. Perry T. L., Wright J. M., Hansen S., MacLeod P. M. Isoniazid therapy of Huntington disease. Neurology. 1979 Mar;29(3):370–375. doi: 10.1212/wnl.29.3.370. [DOI] [PubMed] [Google Scholar]
  8. Sabra A. F., Hallett M., Sudarsky L., Mullally W. Treatment of action tremor in multiple sclerosis with isoniazid. Neurology. 1982 Aug;32(8):912–913. doi: 10.1212/wnl.32.8.912. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES